Humacyte to Present at the H.C. Wainwright BioConnect Invest

DURHAM, N.C., April 28, 2023 -- Humacyte, Inc. , a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced... | April 28, 2023

Related Keywords

Hc Wainwright Bioconnect , Joyce Allaire , Laura Niklason , Dale Sander , Humacyte Inc , Globenewswire Inc , Lifesci Advisors , Nasdaq , Chief Executive Officer , Chief Financial Officer , Bioconnect Investor Conference , Medicine Advanced Therapy , Investor Contact , Media Contact , Humacyte , Nc Stock Exchange , News , Information , Press Release , Pril , 023 , Biotechnology , Platform , Company , Developing , Universally , Implantable , Bioengineered , Human , Issue , It , Commercial , Oday Huma Us44486q1031 ,